Xenon Pharmaceuticals (XENE) PT Raised to $25 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Serge Belanger raised the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $25.00 (from $22.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
